The "Cell and Gene Supply Chain" is the term used to describe the network of processes and facilities involved in the development, manufacturing, distribution, and storage of drugs based on genes and cells. This complex system consists of several stages, including raw material acquisition, gene or cell alteration, quality control, shipment, and patient administration. It is imperative to guarantee the safety and authenticity of these innovative treatments along the whole supply chain in order to provide patients with consistent, efficient, and high-quality care.